The 19th century ushered in a more systematic study of malignant growths, with pioneers like Virchow and Lister laying the groundwork for cellular pathology and surgical intervention. By the early 20th century, advances such as radiotherapy and chemotherapy began to offer tangible hope, though the disease remained largely a death sentence. In the post‑war decades, a surge in public health campaigns and national cancer research institutes signaled a shift from silent suffering to collective responsibility.

Fast forward to the 21st century, where precision medicine, immunotherapy, and global data sharing have transformed prognosis and survival rates. Public figures, including members of the royal family, have amplified these developments through patronage, fundraising, and advocacy, embedding cancer care within the national narrative.